MatchDiary Worldwide, the energy industry is served by McDermott International, Inc.’s engineering, procurement, construction, and technology solutions. North, Central, and South America; Europe, Africa, Russia, and the Caspian; the Middle East and North Africa; Asia Pacific; and Technology make up its five operating segments. It also builds gas-fired power plants, liquefied natural gas import and export terminals, atmospheric and refrigerated storage vessels and terminals, water storage and treatment facilities, pipe and module fabrication, hydrocarbon processing facilities, pipe fabrication and manufacturing, and refinery and petrochemical facilities. It designs, engineers, and builds upstream offshore oil and gas facilities as well as downstream oil and gas facilities. In addition, the business offers technologies for gas processing, refining, petrochemistry, and coal gasification, as well as supplies of equipment, catalysts, and related technical services. 

A cutting-edge social tool called MatchDiary focuses on the demands of football enthusiasts. The purpose of Match Diary is to bring together in one location the largest community in the world that is connected by a love of the game and give them a complete tool to fully appreciate the advantages that the football world has to offer. 

Prices: In the last seven days, the price of Mudra MDR has decreased by 22.92%. The price dropped by 12.82% throughout the course of the last day. Just the previous hour saw a 0.02% decrease in price. The cost per MDR is currently $14.06. Mudra MDR is 4,557.20, or 99.69%, below its all-time high.

There is currently zero MDR in circulation.

Analysis

On the Daily Chart

• The Moving Averages Convergence Divergence (MACD) indicator for MedAdvisor Limited (MDR) is >-0.01, indicating that MedAdvisor Limited is a Buy.
• With a share price of AU$0.23 and a 20-Day Exponential Moving Average of 0.23, MedAdvisor Limited (MDR) is classified as a Sell.
• It is a Sell because MedAdvisor Limited’s (MDR) 50-Day Exponential Moving Average is 0.23 and the share price of 0.23 Australian dollars.

On the Weekly Chart

• The Moving Averages Convergence Divergence (MACD) indicator for MedAdvisor Limited (MDR) is 0.01, indicating that MedAdvisor Limited is a Buy.
• With a share price of AU$0.23 and a 20-Day Exponential Moving Average of 0.23, MedAdvisor Limited (MDR) is classified as a Sell.
• It is a Sell because MedAdvisor Limited’s (MDR) 50-Day Exponential Moving Average is 0.23 and the share price of 0.23 Australian dollars.

Indicators

• The Relative Strength Index (RSI) for MedAdvisor Limited (MDR) is 49.40, producing a Neutral signal.
• The Trend Strength Indicator (ADX) for MedAdvisor Limited (MDR) is 13.73, indicating a Buy.
• The Commodity Channel Index (CCI) for MedAdvisor Limited (MDR) is -45.07, producing a Neutral signal.
• The price rate of change (ROC) for MedAdvisor Limited (MDR) is 4.55, generating a buy signal.

Prediction: 

What will the Mudra MatchDiary cost in 2023?

According to our most optimistic simulation of the Mudra MDR price projection, MDR’s value in 2023 is predicted to increase by 7.73% to $0.182745. In 2023, the cost will range from $0.182745 to $0.142259.

What will the Mudra MDR cost in 2024?

According to our most optimistic simulation of the Mudra MDR price estimate, MDR’s value in 2024 is predicted to increase by 95.99% to $0.332451. In 2024, the cost will range from $0.332451 to $0.125543.

What will the Mudra MDR cost in 2025?

According to our most optimistic simulation of the Mudra MDR price estimate, MDR’s value in 2025 is predicted to increase by 644.91%% to $1.26. In 2025, the cost will range from $1.26 to $0.298165.

What will the Mudra MDR cost in 2030?

According to our latest experimental Mudra MDR price projection simulation, the best-case scenario would see MDR’s value increase by 533.19%% to $1.07 in 2030. In the year 2030, the cost will range from $1.07 to $0.312318.